Clinical Trials in Georgia

Showing 1141-1160 of 16,324 trials

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

NCT06627413

Study ITI-007-037 is a Phase 1b, open-label study to evaluate the safety, tolerability, and PK of lumateperone long-acting injectable (LAI) formulations after a single intramuscular injection in patients with stale schizophrenia or schizoaffective disorder.

Schizophrenia or Schizoaffective

Intra-Cellular Therapies, Inc.52 participantsStarted Aug 2024

Los Alamitos, California, United States • Atlanta, Georgia, United States • Decatur, Georgia, United States +1 more locations

RECRUITINGNA65 miles

The Fourth Left Atrial Appendage Occlusion Study

NCT05963698

LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

Atrial FibrillationStroke, IschemicSystemic Embolism

Hamilton Health Sciences Corporation4,000 participantsStarted Nov 2023

Birmingham, Alabama, United States • Jonesboro, Arkansas, United States • Fountain Valley, California, United States +124 more locations

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

The Fourth Left Atrial Appendage Occlusion Study

Find Trials by Condition in Georgia

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

A Long-term Extension Study of PCI-32765 (Ibrutinib)

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

CLEANer Aspiration for Pulmonary Embolism

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma